↓ Skip to main content

Cochrane Database of Systematic Reviews

Sertindole versus other atypical antipsychotics for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2009
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 tweeters
weibo
1 weibo user

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
130 Mendeley
Title
Sertindole versus other atypical antipsychotics for schizophrenia
Published in
Cochrane database of systematic reviews, April 2009
DOI 10.1002/14651858.cd006752.pub2
Pubmed ID
Authors

Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Sandra Schwarz, Franziska Schmid, Ruth Lewis, Werner Kissling, Stefan Leucht

Abstract

In many countries of the industrialised world second generation (atypical) antipsychotics have become the first line drug treatment for people with schizophrenia. The question as to whether and, if so, how much the effects of the various second generation antipsychotics differ is a matter of debate.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Chile 1 <1%
Unknown 128 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 15%
Researcher 18 14%
Student > Master 18 14%
Student > Doctoral Student 14 11%
Other 9 7%
Other 26 20%
Unknown 25 19%
Readers by discipline Count As %
Medicine and Dentistry 58 45%
Psychology 17 13%
Nursing and Health Professions 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Social Sciences 4 3%
Other 9 7%
Unknown 27 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2017.
All research outputs
#3,349,775
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#5,613
of 8,923 outputs
Outputs of similar age
#48,417
of 192,823 outputs
Outputs of similar age from Cochrane database of systematic reviews
#139
of 205 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,823 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 205 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.